RxDoctor Payments Data

Crystal Gibson, PA

Physician Assistant · Hazard, KYNPI 1174578835

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $8,831 of the $9,596 with a category attached, or 92.0%. Organon accounts for 93.7% of it on its own, with 14 other manufacturers making up the rest. Among physician assistant clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,596in general payments, 2019–2025

Across 46 payments — averaging $208.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organon$9K
  • AbbVie$188
  • Pfizer$85
  • Myovant Sciences Inc.$85
  • Biogen$53
  • Corcept Therapeutics$39
  • plus $160 from 9 others

What the payments were for

  • Speaking & faculty fees$8,83192%
  • Travel & lodging$1562%
  • Food & beverage$6096%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,596 in reported general payments places this provider in the 95th percentile of 1,448 physician assistant providers in Kentucky.

See all physician assistant providers in Kentucky

Medicare billing

Part B allowed, 2024
$1,516
Medicare patients
22
Services billed
46

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Metronidazole13$347
Estradiol-Norethindrone AcetatEstradiol/Norethindrone Acet11$210

Paid to pharmacies, not to this prescriber.

Other physician assistant in Hazard

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →